Related content

Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer

By Kanai Masashi   Matsumoto Shigemi   Nishimura Takahumi   Shimada Yutaka   Watanabe Go   Kitano Toshiyuki   Misawa Akiko   Ishiguro Hiroshi   Yoshikawa Kiyotsugu   Yanagihara Kazuhiro   Teramukai Satoshi   Mitsumori Michihide   Chiba Tsutomu   Sakai Yoshiharu   Fukushima Masanori  

International Journal of Clinical Oncology, Vol. 12, Iss. 3, 2007-06 ,pp. : 224-227

Springer Publishing Company

Access to resources Recommend Favorite

A clinical study of docetaxel with or without 5′DFUR as a second-line chemotherapy for advanced gastric cancer

By Maruta Fukuto   Ishizone Satoshi   Hiraguri Manabu   Fujimori Yoshiro   Shimizu Fumiaki   Kumeda Shigeyoshi   Miyagawa Shinichi  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 71-75

Humana Press, Inc

Access to resources Recommend Favorite

Second-line chemotherapy for advanced gastric cancer in Korea

By Baek Sun   Kim Si-Young   Jeong Jae-heon   Cho Kyung   Yoon Hwi-Joong  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 345-354

Springer Publishing Company

Access to resources Recommend Favorite

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

By Pernot Simon   Mitry Emmanuel   Samalin Emmanuelle   Dahan Laetitia   Dalban Cécile   Ychou Marc   Seitz Jean-François   Turki Hajer   Mazard Thibault   Zaanan Aziz   Lepère Céline   Vaillant Jean-Nicolas   Landi Bruno   Rougier Philippe   Taieb Julien  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 341-347

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

By Feliu J.   Martín G.   Castro J.   Sundlov A.   Rodriguez-Jaráiz A.   Casado E.   Lomas M.   Madroñal C.   Galán A.   Belda C.   Gonzalez-Barón M.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 527-531

Springer Publishing Company

Access to resources Recommend Favorite